Lymphatic Tissue Engineering: A Further Step for Successful Lymphedema Treatment

Andreas Spörlein; Patrick A. Will; Katja Kilian; Emre Gazyakan; Justin M. Sacks; Ulrich Kneser; Christoph Hirche

doi:10.1055/s-0040-1722760

Journal of Reconstructive Microsurgery, Table of Contents

J Reconstr Microsurg 2021; 37(06): 465-474
DOI: 10.1055/s-0040-1722760

Review Article

Lymphatic Tissue Engineering: A Further Step for Successful Lymphedema Treatment

Andreas Spörlein

¹Department of Hand, Plastic, and Reconstructive Surgery, Microsurgery, Burn Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Germany

,

Patrick A. Will

¹Department of Hand, Plastic, and Reconstructive Surgery, Microsurgery, Burn Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Germany

,

Katja Kilian

¹Department of Hand, Plastic, and Reconstructive Surgery, Microsurgery, Burn Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Germany

,

Emre Gazyakan

¹Department of Hand, Plastic, and Reconstructive Surgery, Microsurgery, Burn Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Germany

,

Justin M. Sacks

²Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University, St. Louis, Missouri

,

Ulrich Kneser

¹Department of Hand, Plastic, and Reconstructive Surgery, Microsurgery, Burn Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Germany

,

Christoph Hirche

¹Department of Hand, Plastic, and Reconstructive Surgery, Microsurgery, Burn Center, BG Trauma Center Ludwigshafen, University of Heidelberg, Germany

³Department of Plastic, Hand and Reconstructive Microsurgery, BG Trauma Center Frankfurt, Goethe University Frankfurt, Germany

› Author Affiliations

Abstract

Background Secondary lymphedema, caused by oncologic surgery, radiation, and chemotherapy, is one of the most relevant, nononcological complications affecting cancer survivors. Severe functional deficits can result in impairing quality of life and a societal burden related to increased treatment costs. Often, conservative treatments are not sufficient to alleviate lymphedema or to prevent stage progression of the disease, as they do not address the underlying etiology that is the disruption of lymphatic pathways. In recent years, lymphatic surgery approaches were revolutionized by advances in microsurgical technique. Currently, lymphedema can effectively be treated by procedures such as lymphovenous anastomosis (LVA) and lymph node transfer (LNT). However, not all patients have suitable lymphatic vessels, and lymph node harvesting is associated with risks. In addition, some data have revealed nonresponders to the microsurgical techniques.

Methods A literature review was performed to evaluate the value of lymphatic tissue engineering for plastic surgeons and to give an overview of the achievements, challenges, and goals of the field.

Results While certain challenges exist, including cell harvesting, nutrient supply, biocompatibility, and hydrostatic properties, it is possible and desirable to engineer lymph nodes and lymphatic vessels. The path toward clinical translation is considered more complex for LNTs secondary to the complex microarchitecture and pending final mechanistic clarification, while LVA is more straight forward.

Conclusion Lymphatic tissue engineering has the potential to be the next step for microsurgical treatment of secondary lymphedema. Current and future researches are necessary to optimize this clinical paradigm shift for improved surgical treatment of lymphedema.

Keywords

tissue engineering - lymph nodes - lymphatic vessels - lymphedema - microsurgery

Full Text

References

References
1 Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg 2002; 137 (11) 1253-1257
2 Shih Y-CT, Xu Y, Cormier JN. et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 2009; 27 (12) 2007-2014
3 Ridner SH, Deng J, Fu MR. et al. Symptom burden and infection occurrence among individuals with extremity lymphedema. Lymphology 2012; 45 (03) 113-123
4 Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann N Y Acad Sci 2008; 1131: 147-154
5 Zou L, Liu FH, Shen PP. et al. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study. Breast Cancer 2018; 25 (03) 309-314
6 DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013; 14 (06) 500-515
7 Hirche C, Engel H, Seidenstuecker K. et al. Lympho-reconstructive microsurgery for secondary lymphedema: Consensus of the German-Speaking Society for Microsurgery of Peripheral Nerves and Vessels (DAM) on indication, diagnostic and therapy by lymphovenous anastomosis (LVA) and vascularized lymph node transfer (VLNT). Handchir Mikrochir Plast Chir 2019; 51 (06) 424-433
8 Deng J, Ridner SH, Dietrich MS. et al. Prevalence of secondary lymphedema in patients with head and neck cancer. J Pain Symptom Manage 2012; 43 (02) 244-252
9 Ridner SH, Dietrich MS, Niermann K, Cmelak A, Mannion K, Murphy B. A prospective study of the lymphedema and fibrosis continuum in patients with head and neck cancer. Lymphat Res Biol 2016; 14 (04) 198-205
10 Smith BG, Hutcheson KA, Little LG. et al. Lymphedema outcomes in patients with head and neck cancer. Otolaryngol Head Neck Surg 2015; 152 (02) 284-291
11 Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM. Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer 2010; 116 (22) 5138-5149
12 Hayes SC, Janda M, Ward LC. et al. Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors. Gynecol Oncol 2017; 146 (03) 623-629
13 Mehrara BJ, Greene AK. Lymphedema and obesity: is there a link?. Plast Reconstr Surg 2014; 134 (01) 154e-160e
14 Schmitz KH, Ahmed RL, Troxel A. et al. Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med 2009; 361 (07) 664-673
15 Andersen L, Højris I, Erlandsen M, Andersen J. Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage--a randomized study. Acta Oncol 2000; 39 (03) 399-405
16 Kung TA, Champaneria MC, Maki JH, Neligan PC. Current concepts in the surgical management of lymphedema. Plast Reconstr Surg 2017; 139 (04) 1003e-1013e
17 Dellon AL, Hoopes JE. The Charles procedure for primary lymphedema. Long-term clinical results. Plast Reconstr Surg 1977; 60 (04) 589-595
18 Brorson H. Liposuction in lymphedema treatment. J Reconstr Microsurg 2016; 32 (01) 56-65
19 Basta MN, Gao LL, Wu LC. Operative treatment of peripheral lymphedema: a systematic meta-analysis of the efficacy and safety of lymphovenous microsurgery and tissue transplantation. Plast Reconstr Surg 2014; 133 (04) 905-913
20 Markkula SP, Leung N, Allen VB, Furniss D. Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment. Cochrane Database Syst Rev 2019; 2: CD011433
21 Chang DW, Suami H, Skoracki R. A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg 2013; 132 (05) 1305-1314
22 Yang JC-S, Wu S-C, Lin W-C, Chiang M-H, Chiang P-L, Hsieh C-H. Supermicrosurgical lymphaticovenous anastomosis as alternative treatment option for moderate-to-severe lower limb lymphedema. J Am Coll Surg 2020; 230 (02) 216-227
23 Tourani SS, Taylor GI, Ashton MW. Long-term patency of lymphovenous anastomoses: a systematic review. Plast Reconstr Surg 2016; 138 (02) 492-498
24 Dionyssiou D, Demiri E, Tsimponis A. et al. A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transfer. Breast Cancer Res Treat 2016; 156 (01) 73-79
25 Scaglioni MF, Arvanitakis M, Chen Y-C, Giovanoli P, Chia-Shen Yang J, Chang EI. Comprehensive review of vascularized lymph node transfers for lymphedema: outcomes and complications. Microsurgery 2018; 38 (02) 222-229
26 Cheng M-H, Chen S-C, Henry SL, Tan BK, Lin MC, Huang J-J. Vascularized groin lymph node flap transfer for postmastectomy upper limb lymphedema: flap anatomy, recipient sites, and outcomes. Plast Reconstr Surg 2013; 131 (06) 1286-1298
27 Saaristo AM, Niemi TS, Viitanen TP, Tervala TV, Hartiala P, Suominen EA. Microvascular breast reconstruction and lymph node transfer for postmastectomy lymphedema patients. Ann Surg 2012; 255 (03) 468-473
28 Pons G, Masia J, Loschi P, Nardulli ML, Duch J. A case of donor-site lymphoedema after lymph node-superficial circumflex iliac artery perforator flap transfer. J Plast Reconstr Aesthet Surg 2014; 67 (01) 119-123
29 Coriddi M, Skoracki R, Eiferman D. Vascularized jejunal mesenteric lymph node transfer for treatment of extremity lymphedema. Microsurgery 2017; 37 (02) 177-178
30 Di Taranto G, Chen S, Elia R. et al. Free gastroepiploic lymph nodes and omentum flap for treatment of lower limb ulcers in severe lymphedema: Killing two birds with one stone. J Surg Oncol 2019
31 Baumeister RGH, Mayo W, Notohamiprodjo M, Wallmichrath J, Springer S, Frick A. Microsurgical lymphatic vessel transplantation. J Reconstr Microsurg 2016; 32 (01) 34-41
32 Sabin FR. On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am J Anat 1902; 1: 367-389
33 Pepper MS, Skobe M. Lymphatic endothelium: morphological, molecular and functional properties. J Cell Biol 2003; 163 (02) 209-213
34 Suami H, Scaglioni MF. Anatomy of the lymphatic system and the lymphosome concept with reference to lymphedema. Semin Plast Surg 2018; 32 (01) 5-11
35 Podgrabinska S, Braun P, Velasco P, Kloos B, Pepper MS, Skobe M. Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci U S A 2002; 99 (25) 16069-16074
36 Hu X, Jiang Z, Liu N. A novel approach for harvesting lymphatic endothelial cells from human foreskin dermis. Lymphat Res Biol 2006; 4 (04) 191-198
37 Jiang Z, Hu X, Kretlow JD, Liu N. Harvesting and cryopreservation of lymphatic endothelial cells for lymphatic tissue engineering. Cryobiology 2010; 60 (02) 177-183
38 Marino D, Luginbühl J, Scola S, Meuli M, Reichmann E. Bioengineering dermo-epidermal skin grafts with blood and lymphatic capillaries. Sci Transl Med 2014; 6 (221) 221ra14
39 Conrad C, Niess H, Huss R. et al. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo. Circulation 2009; 119 (02) 281-289
40 Yang Y, Yang J-T, Chen X-H. et al. Construction of tissue-engineered lymphatic vessel using human adipose derived stem cells differentiated lymphatic endothelial like cells and decellularized arterial scaffold: A preliminary study. Biotechnol Appl Biochem 2018; 65 (03) 428-434
41 Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010; 140 (04) 460-476
42 Kaipainen A, Korhonen J, Mustonen T. et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 1995; 92 (08) 3566-3570
43 Mellor RH, Hubert CE, Stanton AWB. et al. Lymphatic dysfunction, not aplasia, underlies Milroy disease. Microcirculation 2010; 17 (04) 281-296
44 Tervala TV, Hartiala P, Tammela T. et al. Growth factor therapy and lymph node graft for lymphedema. J Surg Res 2015; 196 (01) 200-207
45 Honkonen KM, Visuri MT, Tervala TV. et al. Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedema. Ann Surg 2013; 257 (05) 961-967
46 Visuri MT, Honkonen KM, Hartiala P. et al. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study. Angiogenesis 2015; 18 (03) 313-326
47 Yoon YS, Murayama T, Gravereaux E. et al. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J Clin Invest 2003; 111 (05) 717-725
48 Skobe M, Hawighorst T, Jackson DG. et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001; 7 (02) 192-198
49 Kärpänen T, Heckman CA, Keskitalo S. et al. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 2006; 20 (09) 1462-1472
50 Byzova TV, Goldman CK, Pampori N. et al. A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell 2000; 6 (04) 851-860
51 Hartiala P, Saarikko AM. Lymphangiogenesis and lymphangiogenic growth factors. J Reconstr Microsurg 2016; 32 (01) 10-15
52 Sonnenberg E, Meyer D, Weidner KM, Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 1993; 123 (01) 223-235
53 Gibot L, Galbraith T, Kloos B. et al. Cell-based approach for 3D reconstruction of lymphatic capillaries in vitro reveals distinct functions of HGF and VEGF-C in lymphangiogenesis. Biomaterials 2016; 78: 129-139
54 Avraham T, Daluvoy S, Zampell J. et al. Blockade of transforming growth factor-β1 accelerates lymphatic regeneration during wound repair. Am J Pathol 2010; 177 (06) 3202-3214
55 Johnson NC, Dillard ME, Baluk P. et al. Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev 2008; 22 (23) 3282-3291
56 Petrova TV, Karpanen T, Norrmén C. et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 2004; 10 (09) 974-981
57 Strassburg S, Torio-Padron N, Finkenzeller G, Frankenschmidt A, Stark GB. Adipose-derived stem cells support lymphangiogenic parameters in vitro. J Cell Biochem 2016; 117 (11) 2620-2629
58 Knezevic L, Schaupper M, Mühleder S. et al. Engineering blood and lymphatic microvascular networks in fibrin matrices. Front Bioeng Biotechnol 2017; 5: 25
59 Rohringer S, Hofbauer P, Schneider KH. et al. Mechanisms of vasculogenesis in 3D fibrin matrices mediated by the interaction of adipose-derived stem cells and endothelial cells. Angiogenesis 2014; 17 (04) 921-933
60 Yan A, Avraham T, Zampell JC, Haviv YS, Weitman E, Mehrara BJ. Adipose-derived stem cells promote lymphangiogenesis in response to VEGF-C stimulation or TGF-β1 inhibition. Future Oncol 2011; 7 (12) 1457-1473
61 Zhu J, Marchant RE. Design properties of hydrogel tissue-engineering scaffolds. Expert Rev Med Devices 2011; 8 (05) 607-626
62 Chan KLS, Khankhel AH, Thompson RL. et al. Crosslinking of collagen scaffolds promotes blood and lymphatic vascular stability. J Biomed Mater Res A 2014; 102 (09) 3186-3195
63 Helm C-LE, Zisch A, Swartz MA. Engineered blood and lymphatic capillaries in 3-D VEGF-fibrin-collagen matrices with interstitial flow. Biotechnol Bioeng 2007; 96 (01) 167-176
64 Kleinman HK, Martin GR. Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 2005; 15 (05) 378-386
65 Kanapathy M, Kalaskar D, Mosahebi A, Seifalian AM. Development of a tissue-engineered lymphatic graft using nanocomposite polymer for the treatment of secondary lymphedema. Artif Organs 2016; 40 (03) E1-E11
66 Dai Tt, Jiang Zh, Li Sl. et al. Reconstruction of lymph vessel by lymphatic endothelial cells combined with polyglycolic acid scaffolds: a pilot study. J Biotechnol 2010; 150 (01) 182-189
67 Zhang WJ, Liu W, Cui L, Cao Y. Tissue engineering of blood vessel. J Cell Mol Med 2007; 11 (05) 945-957
68 Schaner PJ, Martin ND, Tulenko TN. et al. Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg 2004; 40 (01) 146-153
69 Nakamura M, Arai K, Mimura T. et al. Engineering of artificial lymph node. In: Watanabe T, Takahama Y. eds. Synthetic Immunology. Tokyo, Japan: Springer; 2016: 181-200
70 Randolph GJ, Ivanov S, Zinselmeyer BH, Scallan JP. The lymphatic system: integral roles in immunity. Annu Rev Immunol 2017; 35: 31-52
71 Willard-Mack CL. Normal structure, function, and histology of lymph nodes. Toxicol Pathol 2006; 34 (05) 409-424
72 Lüllmann-Rauch R, Asan E. Taschenlehrbuch Histologie. 5th ed.. Stuttgart, Germany: Thieme Verlag; 2015
73 Rouwkema J, Rivron NC, van Blitterswijk CA. Vascularization in tissue engineering. Trends Biotechnol 2008; 26 (08) 434-441
74 Kobayashi Y, Kato K, Watanabe T. Synthesis of functional artificial lymphoid tissues. Discov Med 2011; 12 (65) 351-362
75 Suematsu S, Watanabe T. Generation of a synthetic lymphoid tissue-like organoid in mice. Nat Biotechnol 2004; 22 (12) 1539-1545
76 Okamoto N, Chihara R, Shimizu C, Nishimoto S, Watanabe T. Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice. J Clin Invest 2007; 117 (04) 997-1007
77 Cuzzone DA, Albano NJ, Aschen SZ, Ghanta S, Mehrara BJ. Decellularized lymph nodes as scaffolds for tissue engineered lymph nodes. Lymphat Res Biol 2015; 13 (03) 186-194
78 Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001; 19 (11) 1029-1034
79 Grikscheit TC, Sala FG, Ogilvie J. et al. Tissue-engineered spleen protects against overwhelming pneumococcal sepsis in a rodent model. J Surg Res 2008; 149 (02) 214-218
80 Frueh FS, Gousopoulos E, Rezaeian F, Menger MD, Lindenblatt N, Giovanoli P. Animal models in surgical lymphedema research--a systematic review. J Surg Res 2016; 200 (01) 208-220
81 Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, Achen MG. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer 2014; 14 (03) 159-172